108 related articles for article (PubMed ID: 16595147)
1. Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer.
Huang FY; Chiu PM; Tam KF; Kwok YK; Lau ET; Tang MH; Ng TY; Liu VW; Cheung AN; Ngan HY
Gynecol Oncol; 2006 Oct; 103(1):219-25. PubMed ID: 16595147
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association.
Chung TK; Cheung TH; Wang VW; Yu MY; Wong YF
Gynecol Obstet Invest; 2001; 52(2):98-103. PubMed ID: 11586036
[TBL] [Abstract][Full Text] [Related]
3. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma.
Peter M; Stransky N; Couturier J; Hupé P; Barillot E; de Cremoux P; Cottu P; Radvanyi F; Sastre-Garau X
J Pathol; 2010 Jul; 221(3):320-30. PubMed ID: 20527025
[TBL] [Abstract][Full Text] [Related]
4. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia.
Menczer J; Fintsi Y; Arbel-Alon S; Tell L; Friedman E; Jackman A; Sherman L
Eur J Gynaecol Oncol; 2000; 21(1):30-4. PubMed ID: 10726615
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
7. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
8. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
9. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
11. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
Liu Y; Lu Z; Xu R; Ke Y
Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
[TBL] [Abstract][Full Text] [Related]
13. Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
Hirose S; Murakami N; Takahashi K; Kuno I; Takayanagi D; Asami Y; Matsuda M; Shimada Y; Yamano S; Sunami K; Yoshida K; Honda T; Nakahara T; Watanabe T; Komatsu M; Hamamoto R; Kato MK; Matsumoto K; Okuma K; Kuroda T; Okamoto A; Itami J; Kohno T; Kato T; Shiraishi K; Yoshida H
Gynecol Oncol; 2020 Jan; 156(1):203-210. PubMed ID: 31757465
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type.
Muller CY; O'Boyle JD; Fong KM; Wistuba II; Biesterveld E; Ahmadian M; Miller DS; Gazdar AF; Minna JD
J Natl Cancer Inst; 1998 Mar; 90(6):433-9. PubMed ID: 9521167
[TBL] [Abstract][Full Text] [Related]
15. Loss of gene function as a consequence of human papillomavirus DNA integration.
Schmitz M; Driesch C; Beer-Grondke K; Jansen L; Runnebaum IB; Dürst M
Int J Cancer; 2012 Sep; 131(5):E593-602. PubMed ID: 22262398
[TBL] [Abstract][Full Text] [Related]
16. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
[TBL] [Abstract][Full Text] [Related]
17. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
18. Low incidence of microsatellite instability in patients with cervical carcinomas.
Rodriguez JA; Barros F; Carracedo A; Mugica-van Herckenrode CM
Diagn Mol Pathol; 1998 Oct; 7(5):276-82. PubMed ID: 9990486
[TBL] [Abstract][Full Text] [Related]
19. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer.
Wilting SM; de Wilde J; Meijer CJ; Berkhof J; Yi Y; van Wieringen WN; Braakhuis BJ; Meijer GA; Ylstra B; Snijders PJ; Steenbergen RD
Genes Chromosomes Cancer; 2008 Oct; 47(10):890-905. PubMed ID: 18618715
[TBL] [Abstract][Full Text] [Related]
20. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
